Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C028474 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of FOXM1 protein | increases expression | 15382178
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of FOXM1 mRNA | affects expression | 21346803
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of FOXM1 protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of FOXM1 mRNA | decreases expression | 20064835
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of FOXM1 mRNA | increases expression | 20713471
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FOXM1 mRNA | decreases expression | 20382639
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene affects the localization of FOXM1 mRNA | affects localization | 12867420
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA | increases expression | 11238010 12867420
|
D002084 |
Butylated Hydroxytoluene |
[Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNA2 mRNA | increases expression | 12867420
|
D002084 |
Butylated Hydroxytoluene |
[Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNB1 mRNA | increases expression | 12867420
|
D002084 |
Butylated Hydroxytoluene |
[Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNE1 mRNA | increases expression | 12867420
|
D002084 |
Butylated Hydroxytoluene |
[Butylated Hydroxytoluene results in increased expression of FOXM1 mRNA] which results in increased expression of CCNF mRNA | increases expression | 12867420
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene results in increased expression of FOXM1 protein | increases expression | 11238010
|
D002084 |
Butylated Hydroxytoluene |
FOXM1 protein affects the susceptibility to Butylated Hydroxytoluene | affects response to substance | 19672312 18345025
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of FOXM1 mRNA | decreases expression | 12414654 15336504
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of FOXM1 mRNA | increases expression | 17256749
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of FOXM1 mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of FOXM1 mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased phosphorylation of FOXM1 protein | increases phosphorylation | 18393292
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of FOXM1 mRNA] | decreases reaction|increases expression | 17854601
|
D004958 |
Estradiol |
ESR1 protein promotes the reaction [Estradiol results in increased expression of FOXM1 mRNA] | increases expression|increases reaction | 20208560
|
D004958 |
Estradiol |
ESR1 protein promotes the reaction [Estradiol results in increased expression of FOXM1 protein] | increases expression|increases reaction | 20208560
|
D004958 |
Estradiol |
Estradiol promotes the reaction [ESR1 protein binds to FOXM1 promoter] | affects binding|increases reaction | 20208560
|
D004958 |
Estradiol |
Estradiol promotes the reaction [[ESR1 protein binds to FOXM1 promoter] which results in increased expression of FOXM1 mRNA] | affects binding|increases expression|increases reaction | 20208560
|
D004958 |
Estradiol |
Estradiol results in increased expression of FOXM1 mRNA | increases expression | 20208560
|
D004958 |
Estradiol |
Estradiol results in increased expression of FOXM1 protein | increases expression | 20208560
|
D004958 |
Estradiol |
FOXM1 protein results in increased susceptibility to Estradiol | increases response to substance | 20208560
|
D004958 |
Estradiol |
Tamoxifen inhibits the reaction [Estradiol promotes the reaction [[ESR1 protein binds to FOXM1 promoter] which results in increased expression of FOXM1 mRNA]] | affects binding|decreases reaction|increases expression|increases reaction | 20208560
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of FOXM1 mRNA | decreases expression | 20208560
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of FOXM1 protein | decreases expression | 20208560
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of FOXM1 mRNA | decreases expression | 12414654
|
D008748 |
Methylcholanthrene |
FOXM1 protein affects the susceptibility to Methylcholanthrene | affects response to substance | 19672312 18345025
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of FOXM1 mRNA | decreases expression | 20059764
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of FOXM1 mRNA] | decreases expression|increases reaction | 20059764
|
C025462 |
sulindac sulfide |
sulindac sulfide results in decreased expression of FOXM1 mRNA | decreases expression | 16184548
|
D013629 |
Tamoxifen |
ESR1 protein inhibits the reaction [Tamoxifen results in decreased expression of FOXM1 mRNA] | decreases expression|decreases reaction | 20208560
|
D013629 |
Tamoxifen |
ESR1 protein promotes the reaction [Tamoxifen results in decreased expression of FOXM1 protein] | decreases expression|increases reaction | 20208560
|
D013629 |
Tamoxifen |
FOXM1 protein affects the reaction [ESR1 protein results in increased susceptibility to Tamoxifen] | affects reaction|increases response to substance | 20208560
|
D013629 |
Tamoxifen |
FOXM1 protein results in decreased susceptibility to Tamoxifen | decreases response to substance | 20208560
|
D013629 |
Tamoxifen |
Tamoxifen inhibits the reaction [Estradiol promotes the reaction [[ESR1 protein binds to FOXM1 promoter] which results in increased expression of FOXM1 mRNA]] | affects binding|decreases reaction|increases expression|increases reaction | 20208560
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [HDAC1 protein binds to FOXM1 promoter] | affects binding|increases reaction | 20208560
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [HDAC2 protein binds to FOXM1 promoter] | affects binding|increases reaction | 20208560
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of FOXM1 mRNA | decreases expression | 20208560
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of FOXM1 protein | decreases expression | 20208560
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of FOXM1 mRNA | decreases expression | 16714409
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FOXM1 mRNA | increases expression | 15667827
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of FOXM1 mRNA | decreases expression | 18230668
|
D014520 |
Urethane |
FOXM1 protein affects the susceptibility to Urethane | affects response to substance | 19672312
|
D014520 |
Urethane |
Urethane results in increased expression of FOXM1 protein | increases expression | 16489016
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of FOXM1 mRNA | decreases expression | 19244175
|
D024483 |
Vitamin K 3 |
Vitamin K 3 results in decreased expression of FOXM1 mRNA | decreases expression | 12414654
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.42 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.72 | 15322242 11752688 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.99 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.01 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.01 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
7.01 | 18316556 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
5.58 | 15814487 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
15.43 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
15.43 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
15.43 | 10545420 6695378 |
MESH:D000236 |
Adenoma |
|
Urethane |
15.43 | 11497255 6695378 17093202 16926031 10530776 10822126 17195641 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
16.52 | 17620307 18056438 19061943 17162532 19052882 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
16.52 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
16.52 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.51 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
3.06 | 18759972 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.83 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.94 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.00 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.23 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.31 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.38 | 11922910 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.72 | 11514358 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.27 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
14.57 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.57 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.57 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.68 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 20208560 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.63 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
4.63 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.63 | 12948864 16675129 17289903 19861407 17261762 18497071 14630087 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
4.63 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
4.63 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.63 | 19200415 19155303 17261762 18997820 21152245 18351453 19103187 20135344 19244106 18821012 19288272 20065188 16273361 19066611 20005174 11161223 19487384 16202921 19410462 19011961 19289846 18629630 17440819 15668708 21138602 19084267 20390343 19189210 18984771 19142967 17049068 19189212 16873071 19115204 17242785 18855134 19059307 17893378 18425577 18815881 20859285 19221464 16818667 20544844 15565566 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.63 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.63 | 16166294 16873071 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.46 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.33 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
9.50 | 16050911 15721981 16124888 15700767 10355542 15673190 16011737 16227642 3786805 16097048 18705752 16192424 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
9.50 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
7.99 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.99 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.38 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.03 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
marker/mechanism |
|
| 17173139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
13.77 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
13.77 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
13.77 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
13.77 | 19394651 18788625 19335982 19208518 3581430 17761372 18978308 20432363 20101231 20214788 19519916 18691550 19107877 18494052 10737359 16681979 16807293 20727157 19383236 16328049 20935162 16935385 19418558 19919837 18971187 10672840 20512989 3084413 18665156 17055752 17428255 18210153 20524982 17162532 18785209 19701751 11831363 19052882 16830150 16569478 16540662 16502159 16698587 18506893 20084675 20514400 21159647 18393292 19539802 18056438 17138121 16878318 19822196 19171122 17173139 17978847 16288022 20007298 16779866 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
13.77 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
13.77 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
13.77 | 1917145 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
marker/mechanism |
|
| 18345025 19672312 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.40 | 12391285 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.44 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.44 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.50 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.30 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.42 | 16936243 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.02 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
20.14 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
20.14 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
20.14 | 17174075 2727394 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
20.14 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
20.14 | 16192471 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.46 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.95 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.95 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.43 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.43 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.03 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
9.61 | 12621046 8697196 16354765 15340226 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
9.61 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
9.61 | 12810352 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.57 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.95 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.68 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.68 | 9142499 17551590 16925845 10589399 9125849 14991402 8800419 9211117 9664655 9224671 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.68 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.88 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.23 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.37 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.11 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.11 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.47 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.47 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.64 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.64 | 15998439 15968718 10092053 16227642 19336974 7440962 6623471 21278145 3732212 9327722 6884620 2869522 7120509 4309450 11566570 19085960 16177239 17522070 3786805 7179309 15027814 10915739 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.64 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.64 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.66 | 11462148 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.57 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.14 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.14 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.51 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.51 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.41 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
11.93 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
11.93 | 19155303 20544844 17893378 16202921 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.93 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.91 | 9294722 10568697 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.99 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.24 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.24 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.51 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.51 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
23.36 | 17595544 12631006 16239168 12795759 15959796 19224547 61145 16045604 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
23.36 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
23.36 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
23.36 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
23.36 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.16 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.33 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.40 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.05 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.81 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
20.06 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
20.06 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
20.06 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
20.06 | 17994277 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.09 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.92 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.47 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.10 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.03 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
15.40 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
15.40 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
15.40 | 14991402 9664655 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
15.40 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
4.15 | 16046796 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.46 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.29 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.21 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.47 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
13.80 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.80 | 16221962 18467677 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.80 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.66 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.90 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
9.62 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
9.62 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.92 | 16354765 16959395 8697196 18606429 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.11 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.40 | 16899240 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.44 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.07 | 20558911 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
4.39 | 17604070 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.78 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.78 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.96 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
3.66 | 11514358 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
7.87 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.87 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.87 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
4.09 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.91 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.91 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.64 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.53 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.53 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.31 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.62 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.62 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
9.62 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.15 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
16.85 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
16.85 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
16.85 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
16.85 | 18625569 |
MESH:D007938 |
Leukemia |
marker/mechanism |
|
| 19436953 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.71 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.58 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.06 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.07 | 12679006 17294898 16140955 19075265 19029980 17107899 17506722 16788101 17368321 17712046 17217047 16823087 16935935 19642359 19225113 17361223 16891316 17339181 16766008 16331271 17301526 15748426 17649720 19035177 9834237 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.21 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.06 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.37 | 11408273 17334410 11903743 17174718 16943688 21278145 16221502 17157831 16239168 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.37 | 18522880 18407596 20032147 19638242 18665156 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
10.68 | 15818738 12958196 12445418 17565644 17922224 18317297 18279442 15052691 17805973 17944888 16638106 17525996 18412020 17976157 17714472 12445421 10355542 17631135 14512876 16192424 12546737 12632512 16248980 15057751 17823541 18705752 14716496 16116963 12389079 18187930 13678700 18418968 15338365 16011737 18205269 15362042 12649538 15123356 16015684 12667390 18210741 16027843 15673190 17766677 15370692 18166357 18395914 18263696 12632514 18481824 15730626 15959796 17761835 17640975 15931870 12741479 17557913 18156304 15925388 12586293 17708605 15876570 12898905 15893842 14620537 18339082 18251166 15650968 18006644 18429990 12666154 15996030 18054572 14748882 17698563 18472332 18376398 16033810 17721639 20821823 17481882 14716833 18472094 11481614 16097048 16136751 18395095 12609069 17869086 17900296 18277467 14724832 18420326 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
10.68 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
10.68 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
10.68 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
10.68 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
10.68 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
10.68 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.96 | 17285989 15720792 15830285 16964402 16246199 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.96 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.03 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.57 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
29.24 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
29.24 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
29.24 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
29.24 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
29.24 | 20405173 19499222 18978307 19254457 2862719 18754104 10737359 21278145 20492335 15175105 19642983 19426721 21167192 20101389 19850985 19638242 19551842 19294768 19256749 19812893 21047994 20452335 9163691 18644402 19996281 18648771 19255062 20501860 20434301 18977376 20118626 15885732 21071580 12771043 19090486 19427195 2422723 19833225 20583210 20137499 19690152 12112319 16942905 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
29.24 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
29.24 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
29.24 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
29.24 | 17559639 17093202 16391232 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
17.79 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
17.79 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
17.79 | 18093689 18544905 19126423 19004024 17942915 18079962 18282651 18775883 16842330 19539802 9362446 19009564 18253720 16267830 17174075 18164116 17854601 18308698 3124819 2563599 19519916 21159647 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
17.79 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.79 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.09 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
marker/mechanism |
|
| 16489016 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
15.13 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
15.13 | 18816296 20869020 18569708 20135361 20464547 20064080 18520028 6695378 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
15.13 | 18597497 16337739 19925653 19359593 11246140 11696405 15390079 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
15.13 | 20970405 20512841 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
15.13 | 15390079 9230183 1399818 7750092 20970405 6695378 16337739 10545420 16271038 21163286 11893704 20512841 17909032 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
15.13 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
15.13 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
15.13 | 12765245 7750092 16289808 11074608 10822126 16337739 10997738 10779650 11544531 17195641 15166089 12117781 11992545 17093202 11807781 11497255 16204055 16391232 12466968 16788158 15902970 10530776 11893704 11246140 17255336 11062179 12957351 11323394 6695378 14587096 11552296 16007126 15136453 16926031 11307925 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
15.13 | 11062179 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.63 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
9.60 | 1500032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.60 | 11408345 17203775 16891317 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.60 | 14580682 19196723 11731420 16827153 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.22 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.22 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.73 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.11 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.11 | 16752155 |
MESH:D008545 |
Melanoma |
|
Vitamin K 3 |
5.11 | 19082730 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.05 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.29 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.66 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.09 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.38 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.01 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.09 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.91 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.91 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.91 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.73 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.56 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.56 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.47 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
11.36 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.36 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.36 | 16594593 16946489 |
MESH:D009369 |
Neoplasms |
|
Urethane |
11.36 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
4.55 | 15582191 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.87 | 19196722 19189210 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.60 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.31 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.17 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.59 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.59 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.59 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
2.97 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.23 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.99 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.78 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.31 | 12819281 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.77 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.77 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
7.77 | 16391232 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.80 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.09 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.09 | 15976015 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.96 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.12 | 12520081 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
5.28 | 16391232 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
5.03 | 11893704 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.43 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.57 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.57 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.06 | 11118676 11896295 11222880 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.76 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.07 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.07 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.07 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.07 | 15084515 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.48 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.18 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.66 | 16723453 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.32 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.98 | 16116481 16283617 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.45 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.41 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
21.70 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
21.70 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
21.70 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
21.70 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
21.70 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
21.70 | 11807781 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.16 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.91 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.26 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.26 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.26 | 17261132 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.41 | 16517955 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.77 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
6.84 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
6.84 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.56 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.67 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.15 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
7.98 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
7.98 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
7.98 | 16712894 8653321 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.18 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.56 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
4.53 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.48 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.85 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.47 | 12125929 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
5.78 | 10620525 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.93 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.12 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.85 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.31 | 17120751 |